Cargando…

Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes

BACKGROUND: The red cell distribution width (RDW) has been shown to be associated with the incidence and complications of type 2 diabetes (T2D). However, the relevance of RDW with the risk of being in poor glycemic control among patients with established T2D is largely overlooked. METHODS: A total o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yaqi, Ye, Sisi, Wang, Haibin, Li, Bing, Wang, Anping, Yan, Wenhua, Dou, Jingtao, Mu, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818876/
https://www.ncbi.nlm.nih.gov/pubmed/29497303
http://dx.doi.org/10.2147/TCRM.S155753
_version_ 1783301098969235456
author Yin, Yaqi
Ye, Sisi
Wang, Haibin
Li, Bing
Wang, Anping
Yan, Wenhua
Dou, Jingtao
Mu, Yiming
author_facet Yin, Yaqi
Ye, Sisi
Wang, Haibin
Li, Bing
Wang, Anping
Yan, Wenhua
Dou, Jingtao
Mu, Yiming
author_sort Yin, Yaqi
collection PubMed
description BACKGROUND: The red cell distribution width (RDW) has been shown to be associated with the incidence and complications of type 2 diabetes (T2D). However, the relevance of RDW with the risk of being in poor glycemic control among patients with established T2D is largely overlooked. METHODS: A total of 702 T2D participants from the REACTION study were enrolled in this study. Blood routine index, fasting plasma glucose, hemoglobin A1c and lipid profile data were available for all of the enrolled population. RESULTS: The univariate logistic analysis revealed a significant association between RDW and the risk of being in poor glycemic control among T2D subjects with an odds ratio (OR) and a 95% confidence interval (CI) of 0.5 and 0.3–0.8, respectively, for the fourth vs the first quartile of RDW. The association strengthened after multivariable adjustment (OR [95% CI]: 0.3 [0.2–0.7]). Interaction and stratified analyses indicated that this association was seen only among T2D subjects with lower body mass index and/or serum lipid levels. CONCLUSION: T2D patients with higher RDW had significantly lower risk of being in poor glycemic control. RDW may contribute to risk assessment for T2D individuals at risk of being in poor glycemic control.
format Online
Article
Text
id pubmed-5818876
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-58188762018-03-01 Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes Yin, Yaqi Ye, Sisi Wang, Haibin Li, Bing Wang, Anping Yan, Wenhua Dou, Jingtao Mu, Yiming Ther Clin Risk Manag Original Research BACKGROUND: The red cell distribution width (RDW) has been shown to be associated with the incidence and complications of type 2 diabetes (T2D). However, the relevance of RDW with the risk of being in poor glycemic control among patients with established T2D is largely overlooked. METHODS: A total of 702 T2D participants from the REACTION study were enrolled in this study. Blood routine index, fasting plasma glucose, hemoglobin A1c and lipid profile data were available for all of the enrolled population. RESULTS: The univariate logistic analysis revealed a significant association between RDW and the risk of being in poor glycemic control among T2D subjects with an odds ratio (OR) and a 95% confidence interval (CI) of 0.5 and 0.3–0.8, respectively, for the fourth vs the first quartile of RDW. The association strengthened after multivariable adjustment (OR [95% CI]: 0.3 [0.2–0.7]). Interaction and stratified analyses indicated that this association was seen only among T2D subjects with lower body mass index and/or serum lipid levels. CONCLUSION: T2D patients with higher RDW had significantly lower risk of being in poor glycemic control. RDW may contribute to risk assessment for T2D individuals at risk of being in poor glycemic control. Dove Medical Press 2018-02-14 /pmc/articles/PMC5818876/ /pubmed/29497303 http://dx.doi.org/10.2147/TCRM.S155753 Text en © 2018 Yin et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Yin, Yaqi
Ye, Sisi
Wang, Haibin
Li, Bing
Wang, Anping
Yan, Wenhua
Dou, Jingtao
Mu, Yiming
Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes
title Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes
title_full Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes
title_fullStr Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes
title_full_unstemmed Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes
title_short Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes
title_sort red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818876/
https://www.ncbi.nlm.nih.gov/pubmed/29497303
http://dx.doi.org/10.2147/TCRM.S155753
work_keys_str_mv AT yinyaqi redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes
AT yesisi redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes
AT wanghaibin redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes
AT libing redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes
AT wanganping redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes
AT yanwenhua redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes
AT doujingtao redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes
AT muyiming redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes